rc 3095 has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ertl, T; Halmos, G; Pinski, J; Qin, Y; Schally, AV; Szepeshazi, K; Yano, T | 1 |
| Cai, RZ; Ertl, T; Halmos, G; Qin, Y; Schally, AV; Szoke, B | 1 |
2 other study(ies) available for rc 3095 and Cancer of Stomach
| Article | Year |
|---|---|
Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Antineoplastic Agents; Binding Sites; Body Weight; Bombesin; Cell Division; Epidermal Growth Factor; Female; Humans; Insulin-Like Growth Factor I; Male; Mice; Mice, Nude; Middle Aged; Molecular Sequence Data; Neoplasm Transplantation; Octreotide; Peptide Fragments; Somatostatin; Stomach Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1994 |
Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.
Topics: Animals; Antineoplastic Agents; Bombesin; DNA, Neoplasm; GTP-Binding Proteins; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Peptide Fragments; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |